Redmile Group’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,952,131
| Closed | -$3.31M | – | 44 |
|
|
2025
Q2 | $3.31M | Hold |
2,952,131
| – | – | 0.35% | 38 |
|
|
2025
Q1 | $3.39M | Hold |
2,952,131
| – | – | 0.32% | 42 |
|
|
2024
Q4 | $18M | Sell |
2,952,131
-120,347
| -4% | -$1.43M | 1.26% | 23 |
|
|
2024
Q3 | $50.8M | Hold |
3,072,478
| – | – | 2.99% | 11 |
|
|
2024
Q2 | $21.1M | Hold |
3,072,478
| – | – | 1.28% | 31 |
|
|
2024
Q1 | $29.6M | Buy |
3,072,478
+100,936
| +3% | +$1.17M | 1.09% | 34 |
|
|
2023
Q4 | $24.7M | Hold |
2,971,542
| – | – | 0.88% | 34 |
|
|
2023
Q3 | $24.8M | Hold |
2,971,542
| – | – | 1.18% | 28 |
|
|
2023
Q2 | $27.4M | Sell |
2,971,542
-362,813
| -11% | -$4.06M | 1.05% | 29 |
|
|
2023
Q1 | $45.8M | Hold |
3,334,355
| – | – | 1.99% | 18 |
|
|
2022
Q4 | $56.7M | Hold |
3,334,355
| – | – | 2.32% | 14 |
|
|
2022
Q3 | $75.8M | Hold |
3,334,355
| – | – | 2.94% | 9 |
|
|
2022
Q2 | $60.1M | Hold |
3,334,355
| – | – | 2.3% | 11 |
|
|
2022
Q1 | $89.1M | Hold |
3,334,355
| – | – | 2.78% | 11 |
|
|
2021
Q4 | $97.8M | Sell |
3,334,355
-91,100
| -3% | -$4.53M | 2.22% | 13 |
|
|
2021
Q3 | $225M | Hold |
3,425,455
| – | – | 3.93% | 3 |
|
|
2021
Q2 | $285M | Hold |
3,425,455
| – | – | 4.22% | 2 |
|
|
2021
Q1 | $263M | Hold |
3,425,455
| – | – | 3.7% | 3 |
|
|
2020
Q4 | $302M | Hold |
3,425,455
| – | – | 3.66% | 5 |
|
|
2020
Q3 | $253M | Buy |
3,425,455
+281,455
| +9% | +$16.7M | 4.64% | 5 |
|
|
2020
Q2 | $230M | Hold |
3,144,000
| – | – | 4.24% | 6 |
|
|
2020
Q1 | $177M | Hold |
3,144,000
| – | – | 4.95% | 5 |
|
|
2019
Q4 | $120M | Hold |
3,144,000
| – | – | 2.87% | 10 |
|
|
2019
Q3 | $55.8M | Buy |
+3,144,000
| New | +$63.5M | 1.87% | 18 |
|
Other funds holding IGMS
Redmile Group's IGMS Position: Q3 2025 in Review
Redmile Group sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 2,952,131 shares — an estimated $3.31M sold.
Redmile Group first reported a position in IGMS in Q3 2019 and held it in 24 quarters. The position peaked at $302M in Q4 2020. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Redmile Group reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Redmile Group sold 2,952,131 IGM Biosciences shares in Q3 2025, an estimated $3.31M.
- Redmile Group first reported a position in IGM Biosciences in Q3 2019 and held it in 24 quarters.
- Redmile Group's IGM Biosciences position peaked at $302M in Q4 2020.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Redmile Group's 13F filing for Q3 2025, filed 14 Nov 2025.